SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-277323
Filing Date
2021-09-20
Accepted
2021-09-20 16:28:02
Documents
12
Period of Report
2021-09-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d235633d8k.htm   iXBRL 8-K 23135
  Complete submission text file 0001193125-21-277323.txt   148069

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrca-20210920.xsd EX-101.SCH 2889
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20210920_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20210920_pre.xml EX-101.PRE 11858
5 EXTRACTED XBRL INSTANCE DOCUMENT d235633d8k_htm.xml XML 3449
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 211263552
SIC: 2834 Pharmaceutical Preparations